Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2008-03-21

Clinical Trial Update: Evaluation of Chylomicrons Metabolism in Sub-Clinical Atherosclerosis in Patients Whit Heterozigous Familial Hypercholesterolemia (FH) Treated With Statin Plus Ezetimibe [NA]

View source ↗

Summary

A clinical trial update examining chylomicron metabolism in sub-clinical atherosclerosis among patients with heterozygous familial hypercholesterolemia treated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EZETIMIBE (EZETIMIBE)
  • Statin (statin)

Snippet

Sponsor: University of Sao Paulo | Conditions: Heterozigous Familial Hypercholesterolemia | NA | Status: UNKNOWN